Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 29 days ago
Share
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension
720 patients around the world
Available in
Spain, Argentina, United States
AstraZeneca
720
Patients around the world
This study is for people with
Arterial hypertension
Uncontrolled arterial hypertension
Requirements for the patient
To 130 Years
All Gender
Medical requirements
Inclusion criteria
Exclusion criteria
See details
Contact us
Contact us
Study
BaxHTN
Sponsor
AstraZeneca
Conditions
Uncontrolled arterial hypertension
Requirements
To 130 Years
All Gender
Unique study ID
clinicaltrials.gov
NCT06034743
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent